晚期内镜成像在炎症性肠病中的应用
该综述检索了PubMed/Medline、Web of Knowledge和Cochrane图书馆,纳入56项临床研究共3296例患者,分析晚期内镜成像技术在炎症性肠病中的应用。结果显示色素内镜联合靶向活检较白光内镜联合随机活检可提高溃疡性结肠炎上皮内瘤变的检出率,内镜共聚焦显微内镜等可实现亚细胞分辨率成像,未报告相关不良事件。
要点
- 色素内镜联合靶向活检较白光内镜联合随机活检提高溃疡性结肠炎上皮内瘤变检出率。
- 内镜共聚焦显微内镜和细胞内镜可实现炎症或肿瘤黏膜的亚细胞分辨率成像。
- 晚期内镜成像技术可行、安全,部分有效,未报告相关不良事件。
核心结论
- 晚期内镜成像技术是可行、安全且部分有效的工具,用于炎症性肠病黏膜炎症的详细诊断和肿瘤检测。
- 这些技术获得的结果可能为炎症性肠病患者的个体化优化治疗提供合理基础。
研究设计与样本
- 系统检索PubMed/Medline、Web of Knowledge和Cochrane图书馆两次,纳入关于炎症性肠病晚期内镜成像的诊断研究。
- 共纳入56项临床研究,合计3296例患者。
主要发现
- 尽管研究间存在显著异质性,色素内镜联合靶向活检较白光内镜联合随机活检在溃疡性结肠炎中检出更高的上皮内瘤变检出率。
- 内镜共聚焦显微内镜和细胞内镜可实现炎症或肿瘤黏膜的亚细胞分辨率成像。
- 内镜共聚焦显微内镜辅助的分子成像可识别黏膜细胞上的膜结合肿瘤坏死因子,作为克罗恩病疾病活动的潜在驱动因素。
- 未报告相关不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究间存在显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Rapid assessment of mucosal inflammation is of crucial importance for the initial diagnosis and the assessment of mucosal healing in inflammatory bowel disease (IBD). Moreover, the identification of intraepithelial neoplasias in IBD is of key relevance for clinical management. Here, we systematically analyzed the utility of advanced endoscopic imaging techniques for optimized diagnosis in IBD. METHODS: PubMed/Medline, Web of Knowledge, and Cochrane library were searched twice for diagnostic studies on advanced endoscopic imaging in IBD. Clinical and technical information was retrieved and subsequently analyzed. Main outcome parameters consisted of the quality of the results, adverse events, and diagnostic yield. RESULTS: Fifty-six clinical studies with a total of 3296 patients were selected for final analysis. Filter technologies permitted a more detailed analysis of mucosal inflammation in IBD. In spite of substantial heterogeneity across studies, dye-based chromoendoscopy with targeted biopsy sampling yielded higher detection rates of intraepithelial neoplasias in ulcerative colitis as compared with white-light endoscopy with random biopsy sampling. Moreover, endocytoscopy and endomicroscopy allowed subsurface imaging of inflamed or neoplastic mucosa in IBD at subcellular resolution. Finally, endomicroscopy-aided molecular imaging enabled the identification of membrane-bound tumor necrosis factor on mucosal cells as a potential driver of disease activity in Crohn's disease. No relevant adverse events were reported. CONCLUSIONS: Advanced endoscopic imaging technologies are feasible, safe, and partially effective tools for detailed diagnosis of mucosal inflammation and detection of neoplasias in IBD. Results obtained from these advanced techniques may provide a rational basis for individualized, optimized therapy for IBD patients.
引用
- Kiesslich R, Neurath MF. Advanced endoscopy imaging in inflammatory bowel diseases. Gastrointest Endosc. 2016. PMID: 27816496. doi:10.1016/j.gie.2016.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。